Here are some highlights from this past week's earnings coverage from BloggingStocks:

• America's Car-Mart Inc. (NASDAQ: CRMT) topped Q1 expectations on strong growth of same-store sales.
• Campbell Soup Co. (NYSE: CPB) strong Q4 results led shares to a new 52-week high.
• FedEx Corp. (NYSE: FDX) boosted its Q1 forecast due to the recent drop in oil prices.
• Krispy Kreme Doughnuts (NYSE: KKD) narrowed its loss in Q2 but fell short of expectations.
• Lehman Brothers Holdings Inc. (NYSE: LEH) released Q3 results early to calm investor concerns.
• PharmaNet Development Group Inc. (NASDAQ: PDGI) was downgraded after lowering its guidance.
• Shuffle Master Inc. (NASDAQ: SHFL) fell short of analysts estimates, reporting flat year over year earnings.
• Texas Instruments Inc. (NYSE: TXN) reaffirmed its outlook when investors had expected a cut.
• Ulta Salon Cosmetics & Fragrance Inc. (NASDAQ: ULTA) beat estimates and offered Q3 and full-year outlook.
• Washington Mutual Inc. (NYSE: WM) was upgraded despite its disappointing Q3 results.

Upcoming quarterly reports include Kroger (NYSE: KR), Adobe (NASDAQ: ADBE), Best Buy (NYSE: BBY), Goldman Sachs (NYSE: GS), General Mills (NYSE: GIS), Morgan Stanley (NYSE: MS), ConAgra (NYSE: CAG), FedEx (NYSE: FDX), and Oracle (NASDAQ: ORCL).

Visit AOL Money & Finance for more earnings coverage.

Earnings highlights: Lehman, Washington Mutual, Campbell, FedEx, Krispy Kreme and others originally appeared on BloggingStocks on Sat, 13 Sep 2008 12:40:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• Banc of America upgraded shares of Pepsi Bottling (NYSE: PBG) to Buy from Neutral on valuation as they expect better leverage in FY09 and believe an overly bearish outlook is priced in. The company's target was raised to $37 from $35.
  
• Goldman upgraded Washington Mutual (NYSE: WM) to Neutral from Sell and said Q3 results were worse than expected but not as bad as the decline in shares suggests. The analyst said WaMu's capital and reserves appear stable and that the company might be able to avoid another capital raise. WaMu's target was raised to $4 from $5.
  
• Greenhill & Co (NYSE: GHL) was raised to Outperform from Market Perform at Wachovia.
  
• F5 Networks (NASDAQ: FFIV) was upgraded at JP Morgan to Overweight from Underweight.
  
• Baird upgraded Gilead Sciences (NASDAQ: GILD) to Outperform from Neutral.

• Jefferies downgraded PharmaNet Development (NASDAQ: PDGI) to Underperform from Buy following the lowered guidance as they believe the company's execution and cost control problems have not been solved. The company's target was lowered to $15 from $27.
  
• JP Morgan downgraded shares of Ericsson (NASDAQ: ERIC) to Underweight from Neutral to reflect their weak outlook for the company's Sony Ericsson (NYSE: SNE) handset unit.
  
• Deutsche Bank downgraded shares of Danaher (NYSE: DHR) to Hold from Buy on valuation and concerns about the company's FX exposure.
  
• Best Buy (NYSE: BBY) was cut to Neutral from Buy at UBS.
  
• Portugal Telecom (NYSE: PT) was lowered to sell from Neutral at UBS and to Underweight from Neutral at JP Morgan.
  
• Quality Systems (NASDAQ: QSII) and BioScrip (NASDAQ: BIOS) were downgraded to Neutral from Buy at Piper.

• Jefferies initiated Massey Energy (NYSE: MEE) with a Buy rating and $80 target. The firm expects substantial margin improvement, free cash flow, and earnings growth with eastern utility coal inventory levels under pressure and a robust export and met coal market.
  
• William Blair started BioMarin Pharmaceutical (NASDAQ: BMRN) with an Outperform rating. The firm expects strong EPS growth during 2008-2010, thinks the company's pipeline is underappreciated by the Street, and feels expectations have been reset to a reasonable level.
• Friedman Billings initiated the Lodging sector with a Market Weight rating, starting InterContinental Hotels (NYSE: IHG) and Marriott (NYSE: MAR) with outperform ratings and targets of $16 and $34, respectively, and Starwood Hotels (NYSE: HOT) with a Market Perform rating.
• Citigroup initiated Diamond Offshore (NYSE: DO) with a Buy rating and $126 target.

Analyst upgrades, downgrades and initiations: PBG, WM, SNE, BBY, MAR... originally appeared on BloggingStocks on Fri, 12 Sep 2008 11:20:00 EST. Please see our terms for use of feeds.

The development of a marketable drug is one of the more expensive endeavors a corporation can undertake. If you have a good idea, but need some help along the way, there is an outfit in Princeton that can back your play.

PharmaNet Development Group (NASDAQ: PDGI) is a drug development company, providing a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The company offers clinical-development solutions, including early and late stage consulting services, Phase I clinical studies, bioanalytical analyses, and Phase II-III-IV clinical development programs. Services include test subject recruitment, data management and assistance with the FDA approval process. The firm operates from thirty-five facilities around the world.

PharmaNet pleased investors earlier in the month, when it reported Q3 EPS of 52 cents (ex-items) and revenues of $99.8 million. Analysts had been expecting 31 cents and $88 million. The CEO noted that the company recorded the highest direct revenues in its history and continued to increase backlog. Management also guided FY07 EPS to $1.22-1.29 ($1.17 consensus) and FY07 revenues to $361-365 million ($348.2M consensus). UBS and Jeffries subsequently declared the stock a "buy" and boosted their targets to the $44-45 range.

Continue reading PharmaNet Development (PDGI): Helping firms develop drugs

PharmaNet Development (PDGI): Helping firms develop drugs originally appeared on BloggingStocks on Wed, 14 Nov 2007 15:45:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY: Clayton, PharmaNet Development, Royal Bank of Scotland, Progressive Gaming and WSFS Financial were today's noteworthy downgrades:

• JMP Securities downgraded shares of Clayton Holdings Inc (NASDAQ: CLAY) to Market Perform from Outperform citing lack of visibility in the non-agency MBS market. William Blair also downgraded shares to Market Perform from Outperform after the company's in-line quarter, to reflect lowered estimates and uncertainty regarding a recovery time.
• Jefferies downgraded shares of PharmaNet Development Group Inc (NASDAQ: PDGI) to Hold from Buy as they believe departures of board and management executives have introduced new risk.
• The Royal Bank of Group PLC (NYSE: RBS) was lowered to Sell from Buy at Citigroup, as they are negative on the company's acquisition of ABN Amro Holding NV (NYSE: ABN).
• ThinkEquity downgraded shares of Progressive Gaming International Corporation (NASDAQ: PGIC) to Accumulate from Buy following Friday's announcement that it lost its post-trial motions and will proceed to appeals court in the Webb lawsuit. PGIC will have to post a $20M bond, which is more than the firm expected.
• B. Riley downgraded shares of WSFS Financial Corporation (NASDAQ: WSFS) to Neutral from Buy after they lowered their estimates to reflect the company's higher projected on-interest expense.

• Goldman removed Hewlett-Packard Company (NYSE: HPQ) from its Conviction Buy List.
• Calyon downgraded VeraSun Energy Corporation (NYSE: VSE) to Add from Buy.
• Merrill Lynch downgraded Aetna Incorporated (NYSE: AET) to Neutral from Buy.
• Friedman Billings downgraded Baker Hughes Incorporated (NYSE: BHI) to Market Perform from Outperform.

Analyst downgrades: CLAY, PDGI, RBS, PGIC and WSFS originally appeared on BloggingStocks on Mon, 29 Oct 2007 10:57:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Wachovia upgraded shares of Sprint Nextel Corporation (NYSE: S) to Outperform from Market Perform as they believe the company is within six months of reaching a sustainable turnaround in subscriber growth and that investor expectations can not get much lower.
• CIBC upgraded shares of Safeway Stores Inc (NYSE: SWY) to Sector Outperformer from Sector Performer after the company's strong quarter in a challenging environment.
• Jefferies raised its rating on PharmaNet Development Group Inc (NASDAQ: PDGI) to Buy from Hold as they believe the company should achieve leverage in margins after executing its turnaround.
• Millennium Pharmaceuticals Inc (NASDAQ: MLNM) was upgraded to Outperform from Neutral at Baird. The firm said expectations for Millennium and Velcade are low and would be buyers for the quarter given the ASH meeting and downstream pipeline visibility.
  
• Telefonica SA (NYSE: TEF) was upgraded to Buy from Hold at Citigroup following the company's earnings growth guidance.

• Centene Corporation (NYSE: CNC) was upgraded to Overweight from Equal Weight at Lehman Brothers.
• UBS upgraded NII Holdings Inc (NASDAQ: NIHD) to Buy from Neutral.
• Goldman Sachs added Knight Capital Group Inc (NASDAQ: NITE) to its Conviction Buy List.
• RBC Capital upgraded Annaly Capital Management (NYSE: NLY) to Outperform from Market Perform.

Analyst upgrades: S, SWY, PDGI, MLNM and TEF originally appeared on BloggingStocks on Fri, 12 Oct 2007 11:00:00 EST. Please see our terms for use of feeds.